Why AstraZeneca Stock Topped the Market on Thursday

Veteran pharmaceutical company AstraZeneca (NASDAQ: AZN) delivered for investors on the second-to-last trading day of the week. Its shares rose by more than 3% across that trading session, thanks mostly to an earnings report that featured a pair of convincing beats. The stock's rise came on a generally gloomy day for the market, as the S&P 500 (SNPINDEX: ^GSPC) slumped by 1.1%. AstraZeneca posted its third-quarter and nine-month figures well before market open that day. These revealed that the company earned nearly $15.2 billion during the former period, a solid 12% higher than in the same quarter of 2024. The company said it saw sales growth in all therapeutic areas, particularly oncology (up 16% year over year) and respiratory and immunology (up 13%). Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool